Orion Corporation (ORNBV) - Financial and Strategic SWOT Analysis Review

Orion Corporation (ORNBV) - Financial and Strategic SWOT Analysis Review

Regular price $300.00 Sale

Published on Jun 06, 2014 - 45 pages

Orion Corporation (ORNBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Orion Corporation (Orion) is a Finland-based pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients, and diagnostic tests. Orion's core therapy areas are central nervous system drugs, oncology and critical care drugs, and pulmonary drugs. Its client base consists of healthcare service providers and professionals, such as doctors, pharmacies, hospitals, healthcare centers, clinics and laboratories. It operates two businesses: Pharmaceuticals and Diagnostics. Major brands of the company include Stalevo, Comtess, Comtan, Dexdomitor, Domitor, Domosedan, Antisedan, Simdax, Marevan, Divina, and Fareston, among others.

Orion Corporation Key Recent Developments

Mar 21, 2014 Orion's pharmaceutical plant opens in Salo - investment will create over 100 jobs
Apr 23, 2013 Orion Reports Revenue Of EUR249.4m In Q1 2013
Feb 26, 2013 Orion Reports Revenue Of EUR980m In 2012

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Orion Corporation - Key Facts
Orion Corporation - Key Employees
Orion Corporation - Key Employee Biographies
Orion Corporation - Major Products and Services
Orion Corporation - Pharmaceutical Pipeline Products Data
Orion Corporation, Pipeline Products by Therapy Area
Orion Corporation, Pipeline Products by Development Phase
Orion Corporation - History
Orion Corporation - Company Statement
Orion Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Orion Corporation - Business Description
Orion Corporation - Corporate Strategy
Orion Corporation - SWOT Analysis
SWOT Analysis - Overview
Orion Corporation - Strengths
Strength - Diversified Business Portfolio
Strength - Strong Market Presence
Strength - Sturdy Research and Development Activities
Orion Corporation - Weaknesses
Weakness - Litigation and Legal Proceedings
Weakness - Limited Liquidity Position
Orion Corporation - Opportunities
Opportunity - Robust Product Pipeline
Opportunity - Strategic Partnerships and Collaborations
Orion Corporation - Threats
Threat - Generic Competition
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Orion Corporation - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company's Lifesciences Financial Deals and Alliances
Orion Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Orion Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Orion Corporation, Recent Deals Summary


Companies Mentioned:

Orion Corporation (ORNBV)